NCT04647643View on ClinicalTrials.gov

Real-World Safety Analysis of Paclitaxel Devices Used for the Treatment of Peripheral Arterial Disease

CompletedOBSERVATIONAL
Enrollment

8,000

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Peripheral Arterial Disease
Interventions
DRUG

Paclitaxel

Paclitaxel to treat peripheral arterial disease

Trial Locations (1)

01805

Lahey Clinic, Inc, Burlington

Sponsors

Lead Sponsor

Lahey Clinic
All Listed Sponsors
collaborator

National Evaluation System for health Technology Coordinating Center

OTHER

collaborator

Society for Vascular Surgery Patient Safety Organization

OTHER

lead

Lahey Clinic

OTHER

NCT04647643 - Real-World Safety Analysis of Paclitaxel Devices Used for the Treatment of Peripheral Arterial Disease | Biotech Hunter | Biotech Hunter